PREDNISOLONE-DARNITSA

The drug has anti-inflammatory, antiallergic, desensitizing, antishock and immunosuppressive effect.

learn more

PREDNISOLONE-DARNITSA

The drug has anti-inflammatory, antiallergic, desensitizing, antishock and immunosuppressive effect.

The drug has anti-inflammatory, antiallergic, desensitizing, antishock and immunosuppressive effect.

Indications for use:

Inflammatory joint disease (rheumatoid arthritis etc.) acute rheumatism; Addison's disease; acute failure of the adrenal cortex ; adrenogenital syndrome; bronchial asthma; asthmatic status; acute and chronic diseases requiring rapid increase in concentrations of glucocorticoids in the body (increased sensitivity to drugs, serum disease, urticaria, allergic rhinitis, hypersensitivity to chemicals, angioedema); hepatitis; hepatic coma; hypoglycaemic conditions; lipoid nephrosis; blood system diseases (agranulocytosis, various forms of leukaemia, thrombocytopenic purpura, haemolytic anaemia); Hodgkin's disease; see more details on application in instructions.

More in instructions (Ukrainian version)
INN
Prednisolonum
Package
5 mg,40 x 5 ml
Form of release
Tablets
АТС class
H02A B06

Other forms of release

  • PREDNISOLONE-DARNITSA 30 mg, 3 x 1 ml

    PREDNISOLONE-DARNITSA

See also

Specialized publications intended for medical institutions and doctors Limitations in obtaining information